type 2 diabetes
Ciloa secures €6.5m from French government to advance obesity and T2 diabetes therapy
July 9, 2025Research and Development Ciloa, Diabetes, France 2030, Obesity, adiponectin, funding, obesity, type 2 diabetes
French biotech company, Ciloa, has received €6.5m in funding through France 2030 to advance its lead candidate, APN-sEV, targeting obesity …
Pila Pharma raises SEK 20m to advance new oral obesity treatment
July 8, 2025Research and Development Novo Nordisk, Obesity, Ozempic, Pila Pharma, Wegovy, obesity, semaglutide, type 2 diabetes
Swedish biotech, Pila Pharma, has raised nearly SEK 20m, equivalent to €1.7m in a capital increase to advance the development …
FDA approves new medicines to treat paediatric type 2 diabetes
June 22, 2023Medical Communications Diabetes, FDA, Synjardy, jardiance, paediatrics, type 2 diabetes
The US Food and Drug Administration (FDA) has announced that it has approved Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin …
Eli Lilly’s Type 2 diabetes drug outperforms semaglutide in trials
June 28, 2021Sales and Marketing Eli Lilly, semaglutide, type 2 diabetes
Eli Lilly has announced that the SURPASS-2 clinical trial has shown tirzepatide achieved superior HbA1C and body weight reductions compared …
Bayer’s cardiovascular drug shows impressive Phase III results
May 11, 2021Manufacturing and Production Bayer, chronic kidney disease, pharma, pharma news, type 2 diabetes
Bayer’s finerenone drug has been shown to significantly reduce cardiovascular death or other cardiovascular events in patients with chronic kidney …
Novo Nordisk launches new Rybelsus pill for type 2 diabetes in the UK
September 2, 2020Research and Development Novo Nordisk, diabetes, type 2, type 2 diabetes
Novo Nordisk’s new type 2 diabetes treatment Rybelsus is now available for doctors and physicians in the UK to prescribe …
New data from diabetes prevention programme shows a reduction of type 2 diabetes
June 17, 2020Research and Development diabetes, type 2 diabetes
The Diabetes Prevention Program Outcomes Study (DPPOS) of 2,000 people showed a significant reduction in the participants’ risk of developing …
Fast-acting mealtime insulin approved for children with diabetes in Canada
March 10, 2020Manufacturing and Production Type 1 diabetes, diabetes, insulin, insulin pump, type 2 diabetes
Health Canada has approved Novo Nordik’s Fiasp, a faster acting mealtime insulin, for children aged 2 and above with type …
The March 2020 issue of Pharmafocus is available to read free online now!
February 27, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing England, Pharmafocus, UK, mumps, pharma, pharmacovigilance, type 2 diabetes
The latest monthly edition of Pharmafocus, the March issue, is available to read for free online now! The coronavirus continues …
Insulin pumps tied to over 2,000 injuries recalled
February 14, 2020Medical Communications Type 1 diabetes, diabetes, insulin, type 1, type 2, type 2 diabetes
Over 300,000 insulin pumps have been recalled by Medtronic after injuries and one death were reported due to devices malfunctioning. …
Type 2 diabetes drug Rosiglitazone increases risk of heart problems
February 12, 2020Research and Development British Medical Journal, diabetes, heart failure, insulin, type 2, type 2 diabetes
A new study has given further evidence that rosiglitazone can contribute to risk of heart problems and heart failure. The …
New report finds that health inequality in the UK greater than previously thought
February 12, 2020Research and Development NHS, NICE, type 2 diabetes
Men are living seven years in poor health while women are living nearly ten years, according to a new report. …
Type 2 diabetes cases up 40% in Scotland
February 11, 2020Manufacturing and Production Type 1 diabetes, diabetes, diabetes obesity, obesity, type 2 diabetes
According to a new study, Scotland’s cases of type 2 diabetes has increased by 40% over the last 10 years. …
Novo Nordisk to offer US patient’s in immediate need free insulin
January 3, 2020Medical Communications Novo, Novo Nordisk, Type 1 diabetes, diabetes, insulin, type 2 diabetes
Novo Nordisk said it would offer free, one-time supply of insulin to those in need, amidst rising insulin prices. Novo …
FDA approves artificial pancreas developed by the University of Virginia
January 2, 2020Business Services, Medical Communications FDA, Pancreas, Type 1 diabetes, diabetes, insulin, type 2 diabetes
The FDA has approved an artificial pancreas system based on technology from the University of Virginia’s Center for Diabetes Technology. …
Latest content
